Ramaschi G, Torti M, Festetics E T, Sinigaglia F, Malavasi F, Balduini C
Department of Biochemistry , University of Pavia, Italy.
Blood. 1996 Mar 15;87(6):2308-13.
CD38 is a cell surface molecule widely used as a marker for immature and activated lymphocytes. It has been recently shown that CD38 displays three enzymatic activities: hydrolysis of NAD+ to ADP-ribose, synthesis of cyclic ADP-ribose from NAD+, and hydrolysis of cyclic ADP-ribose to ADP-ribose. Thus, CD38 plays a key role in the synthesis of cyclic ADP-ribose, a calcium-mobilizing compound. We investigate here the expression and cellular localization of CD38 in human platelets using a specific monoclonal antibody. Results showed that CD38 is expressed by human platelet membranes. Moreover, we show that platelet CD38 possesses NAD glycohydrolase, ADP-ribose cyclase, and cyclic ADP-ribose hydrolase activities. This finding indicates that the calcium-mobilizing agent cyclic ADP-ribose can be synthetized by human platelets and raises the question about the possible role of CD38 expression and enzymatic activities in the signal transduction pathways leading to platelet activation.
CD38是一种细胞表面分子,广泛用作未成熟和活化淋巴细胞的标志物。最近研究表明,CD38具有三种酶活性:将NAD +水解为ADP-核糖、由NAD +合成环ADP-核糖,以及将环ADP-核糖水解为ADP-核糖。因此,CD38在环ADP-核糖(一种钙动员化合物)的合成中起关键作用。我们在这里使用特异性单克隆抗体研究CD38在人血小板中的表达和细胞定位。结果显示,CD38在人血小板膜上表达。此外,我们表明血小板CD38具有NAD糖水解酶、ADP-核糖环化酶和环ADP-核糖水解酶活性。这一发现表明,人血小板可以合成钙动员剂环ADP-核糖,并引发了关于CD38表达和酶活性在导致血小板活化的信号转导途径中可能作用的问题。